Definition of Necitumumab. Meaning of Necitumumab. Synonyms of Necitumumab

Here you will find one or more explanations in English for the word Necitumumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Necitumumab and, of course, Necitumumab synonyms and on the right images related to the word Necitumumab.

Definition of Necitumumab

No result for Necitumumab. Showing similar results...

Meaning of Necitumumab from wikipedia

- Necitumumab (INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic, which is manufactured by Eli Lilly. It binds to the epidermal...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- Margetuximab L01FD07 Zanidatamab L01FE01 Cetuximab L01FE02 Panitumumab L01FE03 Necitumumab L01FF01 Nivolumab L01FF02 Pembrolizumab L01FF03 Durvalumab L01FF04 Avelumab...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- advanced or metastatic SCC. In 2015, FDA also approved the anti-EGFR drug necitumumab for metastatic SCC. 2 October 2015, the FDA approved pembrolizumab for...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...
- Depatuxizumab Depatuxizumab mafodotin ****uximab Imgatuzumab Matuzumab Necitumumab Nimotuzumab Panitumumab Zalutumumab ErbB2/HER2 Agonists: Unknown/none...